| Product NDC: | 40032-030 |
| Proprietary Name: | Monobasic Sodium Phosphate and Dibasic Sodium Phosphate |
| Non Proprietary Name: | Monobasic Sodium Phosphate and Dibasic Sodium Phosphate |
| Active Ingredient(s): | .398; 1.105 g/1; g/1 & nbsp; Monobasic Sodium Phosphate and Dibasic Sodium Phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 40032-030 |
| Labeler Name: | Novel Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079247 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120120 |
| Package NDC: | 40032-030-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (40032-030-01) |
| NDC Code | 40032-030-01 |
| Proprietary Name | Monobasic Sodium Phosphate and Dibasic Sodium Phosphate |
| Package Description | 100 TABLET in 1 BOTTLE (40032-030-01) |
| Product NDC | 40032-030 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Monobasic Sodium Phosphate and Dibasic Sodium Phosphate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120120 |
| Marketing Category Name | ANDA |
| Labeler Name | Novel Laboratories, Inc. |
| Substance Name | SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| Strength Number | .398; 1.105 |
| Strength Unit | g/1; g/1 |
| Pharmaceutical Classes |